Brief: Corline Biomedical signs LOI with Oxford University for clinical study
June 29 (Reuters) - CORLINE BIOMEDICAL AB CLBIO.ST :
* SIGNS LETTER OF INTENT WITH OXFORD UNIVERSITY FOR CLINICAL STUDY CONCERNING TYPE 1
DIABETES
* LOI SIGNED WITH NUFFIELD DEPARTMENT OF SURGICAL SCICENCES AT OXFORD UNIVERSITY
* FORMAL AGREEMENT EXPECTED TO BE SIGNED AFTER SUMMER 2017
Source text for Eikon: ID:nGNE9tWwWC
Further company coverage: CLBIO.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln